December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Ahmed Magdy Rabea: I gave a case presentation in a MTB format during the 3rd Personalized Healthcare Forum in Dubai
Dec 8, 2024, 23:35

Ahmed Magdy Rabea: I gave a case presentation in a MTB format during the 3rd Personalized Healthcare Forum in Dubai

Ahmed Magdy Rabea, Assistant Professor of Medical Oncology and Hematology at the National Cancer Institute, shared a post on LinkedIn:

“I had the opportunity to give a case presentation in a Multidisciplinary Tumor Board (MTB) format during the 3rd PHC (Personalized Healthcare) Forum in Dubai. This standalone meeting, organized by Roche, brought together regional leaders in healthcare to advance our shared mission of personalized medicine.

Presenting in this collaborative environment was not just about sharing insights but also about learning from esteemed colleagues, discussing complex cases, and exploring innovative approaches that drive better outcomes for patients.

It’s inspiring to witness how precision medicine is shaping the future of oncology and beyond. Grateful to Roche for providing this platform and to everyone who contributed to making this event a success.

Looking forward to more opportunities where we can unite expertise, technology, and innovation to redefine healthcare.”

Ahmed Magdy Rabea: I gave a case presentation in a MTB format during the 3rd Personalized Healthcare Forum in Dubai

More posts featuring Ahmed Magdy Rabea.

Dr. Ahmed Magdy Rabea is an Assistant Professor of Medical Oncology and Hematology at the National Cancer Institute. He is also the Head of the Medical Oncology Department at Shifa Hospital and serves as Deputy Head and Consultant of Medical Oncology at Baheya Charity Women’s Cancer Hospital.

Additionally, he is a Consultant of Medical Oncology at As-Salam International Hospital and an Oncology Consultant at the Air Force Specialized Hospital. Dr. Rabea has experience in oncology, with expertise in lung cancer, breast cancer, and multiple myeloma.